|4Mar 7, 9:09 PM ET

Cittadine Andrew 4

4 · Monopar Therapeutics · Filed Mar 7, 2025

Insider Transaction Report

Form 4
Period: 2025-03-04
Cittadine Andrew
Chief Operating Officer
Transactions
  • Award

    Restricted Stock Units

    2025-03-04+40,58151,655 total
    Exercise: $0.00Common Stock (40,581 underlying)
  • Award

    Stock Options

    2025-03-04+43,44543,445 total
    Exercise: $31.70Exp: 2035-03-04Common Stock (43,445 underlying)
Footnotes (2)
  • [F1]Options Vests 6/48ths on June 30, 2025, and 1/48th per month thereafter.
  • [F2]RSUs vest 6/48ths on June 30, 2025, and 3/48ths per quarter thereafter.

Documents

2 files